A Multicenter Study to Evaluate the Safety and Tolerability of Single-Dose for MEDI-545

Clinical trial NCT00472758 · COMPLETED

Trial details

NCT number: NCT00472758
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Plaque Psoriasis

Start date: 2007-02-01
Primary completion: 2008-02-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.